Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Patients With RAD001 With Progressive Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant
- Status
- UNKNOWN
- Phase
- PHASE4
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2